INTRODUCTION
============

Telomeres are specialized protective structures at the ends of linear chromosomes composed of short tandem DNA repeats and associated proteins ([@B7]). Telomere integrity is maintained by shelterin, a six-subunit complex composed of TRF1, TRF2, TIN2, TPP1, POT1, and RAP1 ([@B14]). TRF1 binds telomeres as a dimer and is present at telomeres throughout the cell cycle ([@B53]; [@B10]; [@B5]). TRF1 contains a dimerization domain and a Myb DNA--binding domain, connected by a spatially flexible linker ([@B8]; [@B6]). TRF1 has been described as a negative regulator of telomere length because long-term overexpression of TRF1 leads to gradual telomere shortening, whereas expression of a dominant-negative TRF1 mutant leads to telomere elongation ([@B49]). TRF1 deletion is lethal in the mouse embryo, but no evidence of impaired telomere length or deregulated telomerase activity was observed ([@B23]), suggesting that TRF1 has an essential function that is separate from its role in telomere length regulation.

TRF1 has been implicated in the formation of telomere associations during cell division and carcinogenesis. Associations between sister telomeres have been observed during mitosis upon depletion of tankyrase 1 (a negative regulator of TRF1), with cells arresting in early anaphase with unresolved sister telomeres ([@B17]). Telomere aggregates between telomeres from multiple chromosomes have been observed under both physiological and pathological conditions. During meiotic prophase I of diverse eukaryotes, telomeres naturally cluster together on one side of the nucleus to form a telomere bouquet arrangement, which is believed to facilitate the alignment of chromosomes before homologous recombination and cell division. Taz1, the TRF1/TRF2 fission yeast orthologue, is required for stable association of telomeres during formation of the telomere bouquet ([@B12]) and promotes semiconservative DNA replication through telomeres ([@B32]). Large telomere aggregates ([@B11]; [@B20]; [@B18]), as well as TRF1 overexpression and depletion ([@B29]; [@B33]; [@B52], [@B51]; [@B36]; [@B27]), have been observed in various human cancers; however, the link between telomere aggregation and elevated TRF1 levels is not clear. In vitro, TRF1 protein concentrations at near-saturating levels induce parallel pairing and clustering of telomeric DNA tracts ([@B21]; [@B24]).

Recent studies using enhanced green fluorescent protein--TRF1 implicated TRF1 as a stem cell marker, in that elevated TRF1 levels were found in stem cells and correlated with the formation of teratomas and chimeras ([@B41]). However, the role of TRF1 levels in telomere dynamics and telomere associations in actively dividing stem cells remains unclear. Elevated TRF1 levels have also been linked to cell cycle progression; TRF1 protein levels appear to increase in mitosis and decrease in G1 and S phase ([@B44]; [@B54]). TRF1 association with telomeric chromatin was also observed to increase in mitosis and decrease as cells exit mitosis in *Xenopus* cell extracts ([@B35]). However, it is not known how TRF1 levels affect telomere associations in cells or how important the regulation of TRF1 levels is for proper telomere maintenance.

Here we use high-resolution live-cell imaging to demonstrate that elevated TRF1 levels induce telomere associations in mouse embryonic stem cells. This study demonstrates that precise regulation of TRF1 levels is critical for resolution of telomeres before mitosis to allow proper cell cycle progression and provides novel insight into the role of TRF1 in telomere associations.

RESULTS
=======

Generating cell populations expressing defined TRF1 protein levels
------------------------------------------------------------------

To investigate the role of TRF1 in telomere associations, we followed cells expressing defined levels of fluorescently labeled TRF1 by live-cell imaging. Constructs encoding either *Trf1* fused to Venus yellow fluorescent protein (YFP-TRF1; [@B34]) or *Trf1* cotranscribed but translated separately from YFP by an internal ribosome entry site (IRES) domain (TRF1~IRES-YFP~) were transfected into mouse embryonic stem (ES) cells ([Figure 1A](#F1){ref-type="fig"}). These cells were sorted at 24 h posttransfection by fluorescence-activated cell sorting (FACS) with gating for low (1×), high (10×), or high++ (150×) YFP fluorescence levels ([Figure 1B](#F1){ref-type="fig"}). Western blot analysis shows that YFP can be used as an indicator of TRF1 protein levels in both the YFP-TRF1 and TRF1~IRES-YFP~ strategies ([Figure 1, B--D](#F1){ref-type="fig"}). Two bands around 62 kDa were observed in extracts from cells overexpressing YFP-TRF1. The nature of these two bands is unclear. Despite this uncertainty, we estimate the levels of transfected YFP-TRF1 protein in the low and high populations to be 0.5- to 1-fold and 5- to 10-fold endogenous TRF1 protein levels, respectively ([Figure 1D](#F1){ref-type="fig"}).

![Generating cell populations expressing defined TRF1 protein levels. (A) Schematic of constructs encoding YFP-TRF1 (top) and TRF1 translated separately from YFP (bottom), driven by a CAG promoter. (B) FACS plots showing wild-type control, vector control (IRES-YFP), TRF1~IRES-YFP~, and YFP-TRF1 transfected cells at 24 h posttransfection and gates used to sort negative, low, high, and high++ YFP populations. Numbers in gates indicate fold difference in median YFP levels compared with the low population. (C) Western blot analysis of wild-type control, vector control (IRES-YFP), and TRF1~IRES-YFP~ low and high sorted cell populations (lanes 1--4, respectively) and (D) YFP-TRF1 low (lane 1) and high (lane 2) sorted cell populations using anti-TRF1 antibody or anti-YFP antibody (D, lane 3). Bottom, GAPDH loading control. The molecular weights of TRF1 (solid arrowhead) and YFP-TRF1 (open arrowheads) are indicated. (E) Localization of low YFP-TRF1 (green) over the cell cycle with DAPI DNA stain (blue). Foci doublets in metaphase (insets, arrows) and singlets in anaphase (insets, arrowheads). Images are maximum-intensity projections.](1958fig1){#F1}

Telomere dynamics can be visualized by fluorescently labeled TRF1
-----------------------------------------------------------------

To determine whether the low--YFP-TRF1 population can be used to track telomere dynamics, we imaged cells stably expressing low YFP-TRF1 levels over the cell cycle ([Figure 1E](#F1){ref-type="fig"} and Supplemental Movie S1). In interphase, YFP-TRF1 foci were distributed throughout the nuclear volume. In metaphase and anaphase, YFP-TRF1 foci localized to sister-chromatid ends, suggesting that low levels of YFP-TRF1 correctly localize to telomeres over the cell cycle. As expected, individual TRF1 foci nearly doubled from G1 to G2/M upon sister chromatid separation, with numbers corresponding closely to the expected number of telomeres (Supplemental Figure S1). Therefore cells expressing low levels of YFP-TRF1 can be used to study the dynamic behavior of telomeres in living cells, in line with previous reports ([@B45]; [@B30]).

High TRF1 levels induce TRF1 bridges and mitotic bypass
-------------------------------------------------------

We used live-cell imaging to follow cells with high and high++ YFP-TRF1 levels through mitosis, starting in metaphase. To visualize chromosomes, the cells also stably expressed histone 2B fused to mCherry red fluorescent protein (H2B-RFP; [@B43]). Of the cells that entered anaphase from the high YFP-TRF1 population, the majority (71%) exhibited chromatin bridges composed of several (∼1--15) thin fibers of YFP-TRF1 connecting the chromosomes of segregating daughter cells ([Figure 2, A and B](#F2){ref-type="fig"}, and Supplemental Movie S2).

![TRF1 overexpression induces anaphase bridges containing TRF1, mitotic bypass, and TRF1 aggregates. (A) Time-lapse images of cells expressing low or high YFP-TRF1 (green) levels and H2B-RFP (chromosomes; red). Note the formation of YFP-TRF1 bridges (arrows) between segregating chromosomes, which persist into interphase (bottom). Images are maximum-intensity projections (Supplemental Movies S1 and S2). (B) Quantification of YFP-TRF1 bridges and mitotic bypass from two independent experiments. Percentages are given in brackets. (C) Time-lapse images showing transient YFP-TRF1 bridge (arrowheads). Images are of a single *z*-section (Supplemental Movie S3). (D) Examples of persistent TRF1 bridges between daughter cells in interphase. (E) YFP-TRF1 (green) bridges overlap with telomere FISH probe labeling telomeric DNA (red). Note that images of YFP-TRF1 in fixed cells were acquired before telomere FISH, and images were juxtaposed from previously recorded slide coordinates. (F) Time-lapse images showing mitotic bypass. Note that this cell appears to progress from metaphase directly to interphase without undergoing cell division. (G) Example of an interphase cell expressing high++ YFP-TRF1 exhibiting several large, intense aggregates of YFP-TRF1 foci (arrowheads) connected by thin stretches of YFP-TRF1. Scale bar, 5 μm.](1958fig2){#F2}

We observed two types of bridges---transient and persistent. Transient bridges were composed of thin fibers of YFP-TRF1, which appeared to gradually lengthen and become thinner over time until the bridge was no longer visible, suggesting that bridges may be resolved during mitosis ([Figure 2C](#F2){ref-type="fig"} and Supplemental Movie S3). Transient anaphase bridges almost always severed within the telomere region before nuclear membrane reformation and then rapidly retracted toward opposing poles. This suggests that physical tension rather than cytokinesis is the primary mechanism of transient anaphase bridge resolution. Persistent bridges did not resolve during mitosis and remained in interphase of the following cell cycle (characterized as a TRF1 bridge connecting two cells with decondensed interphase chromatin; [Figure 2, A and D](#F2){ref-type="fig"}). Persistent bridges were often composed of multiple TRF1 fibers with high amounts of YFP-TRF1 within the bridge. These results suggest that the severity of the bridge determines the outcome of mitosis; minor bridges may be resolved during mitosis, whereas more-severe bridges persist for the duration of mitosis.

TRF1 bridges were also induced by TRF1 alone, translated separately from YFP (Supplemental Figure S2), suggesting that the bridges observed in YFP-TRF1--overexpressing cells are not a dominant-negative effect of the fluorescent protein fusion to TRF1. Because TRF1 proteins bind telomere repeats ([@B8]), we reasoned that the TRF1 bridges likely contain telomeric DNA. To confirm this, we performed fluorescence in situ hybridization (FISH) using a telomere probe to label telomeric DNA within the chromatin bridges. YFP-TRF1 bridges overlapped closely with signals from the telomere FISH probe ([Figure 2E](#F2){ref-type="fig"}), showing that chromatin bridges are composed of YFP-TRF1 protein and tracts of telomeric DNA.

To determine whether telomere associations undergo DNA repair, we assayed for colocalization of TRF1 bridges with regulator of telomere length 1 (RTEL1). RTEL1 is required for telomere maintenance ([@B15]; [@B48]) and suppresses homologous recombination during DNA repair ([@B4]; [@B47], [@B46]). We observed that RTEL1-YFP formed distinct foci that specifically colocalized to the extremities of *persistent* TRF1 bridges (Supplemental Figure S3). Of the cells exhibiting persistent RFP-TRF1 bridges, 5--30% contain RTEL1-YFP foci that colocalize with the persistent bridges (*n* = 30). Note that RTEL1-YFP photobleached rapidly during image acquisition. However, RTEL1 did not colocalize with the majority of *transient* telomere bridges or telomere aggregates. In addition, we did not observe a clear correlation between TRF1 aggregate size and RTEL1 colocalization. This is consistent with our previous study showing that, at any given time, the majority of RTEL1 and TRF1 foci do not colocalize ([@B46]).

To determine how elevated TRF1 levels affects cell cycle progression, we followed cells expressing high YFP-TRF1 by live-cell imaging. We observed that 75% of cells that started in metaphase bypassed mitosis and failed to divide to form separate nuclei (mitotic bypass). These cells instead proceeded to form a single (tetraploid) nucleus in interphase ([Figure 2, B and F](#F2){ref-type="fig"}). By contrast, none of the cells in the low--YFP-TRF1 population underwent mitotic bypass. Of note, daughter cells in interphase that remained linked by persistent YFP-TRF1 bridges ([Figure 2, A and D](#F2){ref-type="fig"}) were not included as having bypassed mitosis; however, these cells were occasionally observed to fuse and then undergo mitosis, giving rise to tetraploid cells that often underwent apoptosis (unpublished data). This is consistent with studies showing that persistent telomere dysfunction in p53-deficient cells leads to tetraploidization and mitotic bypass ([@B13]).

High TRF1 levels induce telomere associations
---------------------------------------------

In cells expressing high++ levels of YFP-TRF1, we observed interphase cells with large aggregates of YFP-TRF1 connected by thin stretches of YFP-TRF1 ([Figure 2G](#F2){ref-type="fig"}), suggesting that telomere associations may occur between multiple chromosomes. To test this hypothesis, we prepared metaphase chromosome spreads of cells overexpressing TRF1~IRES-YFP~, YFP-TRF1, and an IRES-YFP control. To increase the amount of cells used for metaphase spreads, we set FACS gates for sorting to include cells with high or greater YFP levels. We labeled telomeres using a telomere-specific FISH probe. Normally, sister telomeres are resolved into distinct foci. We observed single or joined sister telomeres at the long arm in up to 15% of telomeres in TRF1~IRES-YFP~-overexpressing cells ([Figure 3, B and C](#F3){ref-type="fig"}). Of note, we observed these telomere associations despite using hypotonic treatment in our preparation of metaphase chromosome spreads, which may release some but not all proteins from chromosomes ([@B37]; [@B17]). In IRES-YFP control cells, single and joined telomeres were less frequent (\<1%; [Figure 3A](#F3){ref-type="fig"}). Occasionally, we observed telomere associations between telomeres from different chromosomes in TRF1~IRES-YFP~-overexpressing cells ([Figure 3D](#F3){ref-type="fig"}). This was more pronounced in YFP-TRF1--overexpressing cells, in which large, intense aggregates of telomere foci were observed, indicating that telomeres from different chromosomes were joined ([Figure 3E](#F3){ref-type="fig"}). Each telomere aggregate was surrounded by multiple (up to seven) radially distributed chromosomes. Multiple telomeric signals characteristic of fragile telomere phenotypes were also observed ([@B42]). The chromosomes appeared thinner immediately adjacent to telomere aggregates, suggesting that the chromosomes are physically stretched from the attachment point at the aggregate. These results suggest that TRF1 overexpression can induce two forms of telomere associations---single or joined sister telomeres---as well as telomere aggregates between multiple chromosomes.

![TRF1 overexpression induces telomere associations. Examples of metaphase chromosome spreads in mouse ES cells transiently expressing high or greater YFP levels for (A) vector control (IRES-YFP) or (B) TRF1~IRES-YFP~ at ∼72 h posttransfection. Telomere DNA was labeled by a telomere FISH probe conjugated to Cy5 (green), and DNA was stained with DAPI (blue). (C) Column scatter plot showing percentage of single or joined telomeres at long arm. The *p* value was calculated using an unpaired two-tailed *t* test. Mean ± SEM is indicated. (D) Examples of telomere associations between metaphase chromosomes (arrowheads) in TRF1~IRES-YFP~ overexpressing cells and (E) YFP-TRF1 overexpressing cells at ∼72 h posttransfection. Inverted DAPI images (E, left). Insets show telomere aggregates for which each telomere aggregate is surrounded by multiple (up to seven) radially distributed chromosomes. Gamma was set to 0.5 for images in E to visualize lower-intensity signals.](1958fig3){#F3}

Development of TRF1 cleavage assay in mammalian cells
-----------------------------------------------------

Because we observed that TRF1 protein levels must be tightly regulated for telomere resolution, we reasoned that telomere associations could result from TRF1 protein physically bridging telomeres together. To test this hypothesis, we used tobacco etch virus (TEV) protease to rapidly cleave TRF1 protein and followed the progression of telomere resolution by live-cell imaging. If telomere associations are mediated by TRF1, then cleavage of TRF1 protein should resolve telomere aggregates. To make TRF1 protein cleavable, we inserted a TEV protease recognition site in the flexible linker of YFP-TRF1 (YFP-TRF1~TEV~; [Figure 4A](#F4){ref-type="fig"}). Because the flexible linker is poorly conserved, we reasoned that the TEV protease recognition site should not interfere with cleavable TRF1 binding to telomeres before induction of cleavage by TEV protease. To enable inducible expression of cleavable TRF1, we also fused YFP-TRF1~TEV~ to an FK506-binding protein (FKBP) degradation domain, which can be stabilized by Shield-1 ([@B3]). However, this system was not strong enough to induce the TRF1 levels required for telomere aggregation. Therefore we generated a stable clone expressing low levels of FKBP-YFP-TRF1~TEV~ and transiently transfected these cells with FKBP-YFP-TRF1~TEV~ in the presence of Shield-1 to overexpress and stabilize the cleavable FKBP-YFP-TRF1~TEV~ protein. Note that a second transfection with FKBP-YFP-TRF1~TEV~ was required, most likely because not enough of the overexpressed FKBP-YFP-TRF1~TEV~ was stabilized by Shield-1 to induce telomere aggregates in the stable clone. Cells were then sorted for high++ levels of FKBP-YFP-TRF1~TEV~ (FACS gating was the same as in [Figure 1B](#F1){ref-type="fig"}, high++ gate) to be imaged at 24--48 h posttransfection and ∼3--10 h postsorting. TRF1 cleavage was induced by transient transfection with TEV protease fused to cerulean cyan fluorescent protein (CFP; [@B40]), driven by a cytomegalovirus early enhancer/chicken β-actin (CAG) promoter or a phosphoglycerate kinase (PGK) promoter as specified ([Figure 4A](#F4){ref-type="fig"}). To facilitate nuclear entry of TEV protease, TEV protease was also flanked by nuclear localization signals as previously reported ([@B39]). To visualize telomeres before and after detection of CFP-TEV protease by live-cell imaging, cells stably expressed low levels of noncleavable RFP-TRF1 ([Figure 4A](#F4){ref-type="fig"}). Because RFP-TRF1 was expressed at levels comparable to endogenous TRF1 (unpublished data), we expected that RFP-TRF1 could be used as a faithful indicator of telomere distribution and would not induce telomere aggregates by itself.

![Resolution of telomere aggregates by TRF1 cleavage. (A) Schematic of constructs for TRF1 cleavage assay: cleavable FKBP-YFP-TRF1~TEV~ showing TRF1 domains with cleavage site (purple) inserted in flexible linker, noncleavable RFP-TRF1 to visualize telomeres, and CFP-TEV protease driven by a CAG promoter (or a PGK promoter in D). (B) Projection images of cells expressing high levels of cleavable FKBP-YFP-TRF1~TEV~ (green) and low levels of noncleavable RFP-TRF1 (red) for three time points before and after detection of CFP-TEV protease (blue). RFP-TRF1 foci selected using automatic thresholding of fluorescence intensity (bottom), with each color representing one selected focus. (C) Column scatter plot showing average intensity of foci (sum) on a log scale for three time points before and after detection of CFP-TEV protease or CFP control, where each dot represents an individual selected focus, and each color represents an individual cell. The number of selected foci (*n*) for each time point is indicated in brackets. Time-lapse movies of nine and seven cells are represented for CFP-TEV protease and a CFP control, respectively (legend). The *p* values for *T* = 1 compared with *T* = 4--6 was calculated using an unpaired two-tailed *t* test. Error bars, SEM. (D) Projection images from a time-lapse movie of cells expressing high levels of cleavable FKBP-YFP-TRF1~TEV~ (green) and low levels of noncleavable RFP-TRF1 (red) upon transfection with PGK-CFP-TEV protease, showing time after transfection. Note that FKBP-YFP-TRF1~TEV~ fluorescence becomes diffuse (indicating that cleavage has occurred), and noncleavable RFP-TRF1 aggregates become smaller and more uniform (insets; see Supplemental Movie S4). Scale bar, 5 μm.](1958fig4){#F4}

To visualize TRF1 cleavage in real time, we transiently transfected cells stably expressing low levels of noncleavable RFP-TRF1 (red) and high++ levels of cleavable FKBP-YFP-TRF1~TEV~ (green) with CFP-TEV protease (blue) or a CFP control, followed by live-cell fluorescence imaging. Before detection of CFP-TEV protease, large aggregates of TRF1 foci were observed as overlapping signals in both the YFP and RFP fluorescence channels, indicating that both the cleavable (green) and noncleavable (red) TRF1 fusion proteins colocalize ([Figure 4B](#F4){ref-type="fig"}, time points 1--3). The detection of nuclear CFP (blue) fluorescence indicated successful expression and nuclear entry of CFP-TEV protease ([Figure 4B](#F4){ref-type="fig"}). If TRF1 cleavage was successful, we expected that the cleaved N-terminal portion of FKBP-YFP-TRF1~TEV~ would dissociate from telomeres ([Figure 5B](#F5){ref-type="fig"}). Indeed, we observed a distinct change in YFP localization from distinct foci to diffuse fluorescence, which occurred simultaneously with detection of CFP-TEV protease ([Figure 4B](#F4){ref-type="fig"}). This suggests that both the detection of CFP-TEV protease and diffuse YFP localization can serve as timing indicators of TRF1 cleavage. Therefore we developed a novel assay that combines site-specific protein cleavage of TRF1 by TEV protease with live-cell fluorescence imaging in a mammalian system.

![Model of TRF1-mediated telomere associations. (A) *Cis*-TRF1 conformation showing YFP on N-terminus and TEV cleavage site inserted in flexible linker domain. (B) *Trans*-TRF1 conformation may promote associations between telomeres under conditions in which telomere-binding sites are saturated with high levels of TRF1. (C) Model showing TRF1-mediated telomere associations in a cellular context and potential consequences. Telomere associations may occur by increase in TRF1 levels, decrease in telomere length (assuming TRF1 levels remain relatively constant), or under conditions that promote the *trans*-TRF1 conformation. Two main types of telomere associations may form: between sister telomeres and between telomeres from different chromosomes. Persistent telomere bridges may recruit DNA repair proteins, such as the helicase RTEL1, for resolution and repair. Telomere bridges may lead to DNA breakage within chromosomes or telomeres, and broken ends may continue to fuse and break in subsequent cell cycles, giving rise to genomic instability.](1958fig5){#F5}

Resolution of telomere aggregates by TRF1 cleavage
--------------------------------------------------

Because RFP-TRF1 indicates telomere distribution within the cells, this enabled us to monitor telomere aggregates before and after detection of CFP-TEV protease. Images were acquired for three time points in individual cells before and after detection of CFP-TEV protease ([Figure 4B](#F4){ref-type="fig"}). RFP-TRF1 foci were selected using automatic selection of threshold fluorescence intensity, and the intensity (sum) of each focus was measured ([Figure 4B](#F4){ref-type="fig"}, bottom). After detection of CFP-TEV protease, the RFP-TRF1 foci were smaller and more uniform, indicating that telomere aggregates were resolved ([Figure 4B](#F4){ref-type="fig"}, insets, and [Figure 4C](#F4){ref-type="fig"}, right). We also observed an increase in the number of foci after TRF1 cleavage; however, this increase was difficult to measure above background fluorescence by automatic selection of threshold fluorescence ([Figure 4B](#F4){ref-type="fig"}). In contrast, cells transfected with a CFP control did not show a significant change in the intensity ([Figure 4C](#F4){ref-type="fig"}, left) or number of foci. In cells overexpressing YFP-TRF1 without the cleavage site, large telomere aggregates remained upon detection of CFP-TEV protease, suggesting that TEV protease cleavage is specific to TRF1 at the inserted cleavage site, as opposed to nonspecific sites. Of note, cells often underwent mitosis upon detection of CFP-TEV protease, suggesting that upon TRF1 cleavage, cells were released from a mitotic block and resumed cell cycle progression (unpublished data).

To determine how lower expression of TEV protease would affect telomere resolution, we generated cells in which CFP-TEV protease was driven by a lower-expressing PGK promoter. The change in fluorescence of FKBP-YFP-TRF1~TEV~ from distinct foci to diffuse fluorescence served as the indicator of TRF1 cleavage. We observed that the FKBP-YFP-TRF1~TEV~ fluorescence became gradually diffuse at a slower rate with the PGK-CFP-TEV protease than with the CAG-CFP-TEV protease. This corresponded closely with a dramatic increase in the number of noncleavable RFP-TRF1 foci and a decrease in focal intensity; however, foci numbers were difficult to measure above background fluorescence by automatic thresholding ([Figure 4D](#F4){ref-type="fig"} and Supplemental Movie S4). Taken together, these results suggest that telomere aggregates are mediated by TRF1 and cleavage of TRF1 dimers resolves telomere associations and allows cell cycle progression.

Telomere aggregation before telomere resolution affects cell cycle progression and survival
-------------------------------------------------------------------------------------------

Previous studies showed that truncated TRF1 containing the Myb domain but not the dimerization domain does not bind TTAGGG repeats ([@B5]). On the basis of this study, we expected that removal of TRF1 and associated shelterin components from the telomere upon TRF1 cleavage could lead to telomere dysfunction/deprotection and induction of apoptosis. After the induction of telomere aggregation by overexpressing FKBP-YFP-TRF1~TEV~ for 24-48 h, TEV protease was expressed. We found that, on average, 14 h after CFP-TEV protease detection, cleavage of TRF1 leads to cell cycle arrest, followed by apoptosis in \>80% of cells (*n* = 14). In these live-cell imaging experiments, cell cycle arrest was defined as absence of cell division over 48 h, and apoptosis was observed by brightfield imaging as membrane blebbing and cell breakdown. Of note, one cell underwent cell division and did not undergo apoptosis over the 48-h imaging duration.

We next determined whether TEV protease itself or the cleaved TRF1 products could negatively affect cell cycle progression and cell survival. Cells stably expressing noncleavable RFP-TRF1 (to visualize telomere foci) were cotransfected with PGK-CFP-TEV protease and cleavable FKBP-YFP-TRF1~TEV~ and followed by live-cell imaging 24 h after transfection. We found that the telomere phenotype appeared normal in these cells, with no observed telomere bridges or large telomere aggregates. These cells actively divided, and telomere bridges were not observed in anaphase of mitotic cells (*n* = 10). However, two mitotic cells exhibited discrete lagging RFP-TRF1 foci between the segregating daughter cells in anaphase. Furthermore, we did not observe large telomere aggregates in interphase cells 24 h after transfection, and the number of noncleavable RFP-TRF1 foci was similar to that in an untransfected control (Supplemental Figure S4).

Taken together, our observations suggest that although the assay components themselves appear to be nontoxic, telomere clustering and cleavage can be toxic once telomere clusters are formed.

DISCUSSION
==========

We developed a system for visualization of telomere and chromosome dynamics using multicolor, high-resolution live-cell imaging. Using this system, we examined cells expressing defined levels of TRF1 protein and demonstrated that elevated TRF1 levels (≥10 times endogenous TRF1 levels) induce telomere anaphase bridging, TRF1 aggregates, and mitotic bypass. Our findings provide insight into how high TRF1 levels influence telomere dynamics and telomere associations in rapidly dividing pluripotent stem cells and support the concept that precise regulation of cellular TRF1 levels is essential for telomere resolution and proper mitotic progression.

Analysis of telomeric DNA distribution in metaphase chromosomes revealed two forms of telomere associations---single or joined sister telomeres---as well as telomere aggregates between multiple chromosomes. This is consistent with previous in vitro studies showing that moderate TRF1 concentrations (two monomers per telomere repeat) lead to parallel pairing of DNA probes containing tracts of telomeric DNA, whereas high TRF1 concentrations (greater than five monomers per telomere repeat) lead to aggregates containing many DNA molecules ([@B21]), suggesting that the phenotypic outcome of TRF1 overexpression is dependent on the ratio of TRF1 to telomere repeats.

We developed a novel assay that combines site-specific protein cleavage of TRF1 by TEV protease with live-cell fluorescence imaging in a mammalian system. We observed that the cellular localization of fluorescent cleavable TRF1 changed from distinct foci to diffuse fluorescence at the same time as detection of nuclear TEV protease, suggesting that TRF1 was successfully cleaved. We observed that telomere aggregates induced by TRF1 overexpression are resolved upon TEV protease--mediated TRF1 cleavage, suggesting that telomere associations result primarily from TRF1-mediated protein interactions. Our findings demonstrate for the first time that telomere associations are mediated by TRF1 in a mammalian system.

Elevated TRF1 levels have been observed under physiological conditions, such as in pluripotent stem cells ([@B41]) and during mitosis ([@B44]; [@B35]; [@B54]). The phenotypes we observe at exogenous high TRF1 levels may be indicative of TRF1 function under physiological conditions, at which endogenous TRF1 levels may increase to a certain degree, but under precisely regulated conditions. For instance, TRF1-mediated telomere associations could function to hold telomeres in close proximity during meiotic telomere bouquet formation to facilitate alignment of chromosomes before homologous recombination ([@B12]), as a cohesion mechanism between sister telomeres from replication until mitosis ([@B2]; [@B17]), to facilitate telomere recombination and repair, and to create localized areas for limiting telomere maintenance factors such as telomerase.

TRF1-mediated telomere associations could also play key roles under pathological conditions, such as carcinogenesis. It will be important to determine whether there is a link between telomere aggregation observed in human cancer cells ([@B11]; [@B20]; [@B18]) and the elevated TRF1 levels observed in such cells ([@B29]; [@B36]).

We find that embryonic mouse ES cells, which lack a functional p53 checkpoint ([@B1]), progress through mitosis in the presence of unresolved telomeres, giving rise to anaphase bridges at telomeres and mitotic bypass. In contrast, 3T3 mouse fibroblasts undergo mitotic arrest upon TRF1 overexpression (unpublished data), consistent with previous studies showing mitotic arrest in the presence of unresolved telomeres in HeLa cells ([@B17]). It will be important to determine how cell type, checkpoint control, and differentiation affect cell cycle progression in the presence of unresolved telomeres.

A potential mechanism for TRF1-mediated telomere associations could be that as telomeres shorten (by aging or disease), the relative concentration of TRF1 per telomere repeat increases (assuming that TRF1 levels remain relatively constant), leading to TRF1-mediated telomere associations ([Figure 5C](#F5){ref-type="fig"}). Normal human cells display persistent telomere cohesion and anaphase delay before senescence, which can be overcome by overexpression of tankyrase, a major regulator of TRF1 levels ([@B25]). Imbalance between number of telomere repeats and TRF1 levels could result in relative overexpression of TRF1, resulting in the telomere associations that have been described. Flexible TRF1 dimers could mediate telomere associations by binding telomeres in a *trans* conformation, with the DNA-binding domain of each monomer binding opposing telomeres ([Figure 5B](#F5){ref-type="fig"}), in contrast to a *cis* conformation, with binding to adjacent sites on the same telomere ([Figure 5A](#F5){ref-type="fig"}). This is in line with previous in vitro studies showing that TRF1 protein alone induces parallel pairing and looping of telomeric DNA tracts when the ratio of telomere binding sites is limiting compared with TRF1 levels ([@B21]; [@B6]). Our findings show that elevated levels of TRF1 induce telomere associations in cells, which manifest as telomere bridges and mitotic bypass ([Figure 5C](#F5){ref-type="fig"}). In our studies, the telomere binding sites were likely limiting relative to TRF1 protein levels, supporting the hypothesis that competition for binding sites results in TRF1 dimers binding in a *trans* conformation.

Telomeres initially held in close proximity by a TRF1-mediated protein interaction may eventually progress to interactions between telomeric DNA. DNA-mediated interactions can arise via processes such as recombination, telomere fusion, stalled telomere replication, or DNA catenation. Although we occasionally observed metaphase chromosomes positioned end to end, the predominant phenotype in TRF1-overexpressing cells was sister telomere associations and telomere aggregates surrounded by multiple radially distributed chromosomes. Large telomere aggregates formed almost immediately after TRF1 overexpression, indicating that the primary outcome of elevated TRF1 levels is telomere associations as opposed to stalled telomere replication, which would be expected to lead primarily to sister telomere associations. Furthermore, since each telomere aggregate involves multiple (up to seven) chromosomes, it is unlikely that this is a result of end-to-end covalent fusions, which would be expected to lead to a linear positioning of chromosomes ([@B50]; [@B22]) in which each fusion point involved a maximum of two chromosomes linked end to end.

It is feasible that the close proximity of clustered telomeres facilitates recombination events such as telomere strand exchange by invasion of the 3′ single-stranded telomere overhang in-*trans*. RTEL1 may be recruited to these sites to reverse inappropriate strand invasion, in line with previous studies showing that RTEL1 dissociates displacement loops (D loops) formed at the site of strand invasion ([@B4]; [@B48]). We observed that RTEL1 forms distinct foci that specifically localize to the extremities of persistent bridges. It is possible that TRF1 bridges that persisted into the following cell cycle are more likely to have undergone recombination events that require recruitment of DNA repair proteins such as RTEL1. We previously showed that RTEL1 is recruited to distinct foci at sites of DNA repair; RTEL1 foci colocalized with almost all 53BP1 and FANCD2 foci upon treatment with DNA-damaging agents ([@B46]). Resolution of telomere aggregates may be important for telomere protection by allowing individual telomeres to fold back in a telomere loop (T-loop) by strand invasion in-*cis*. It is tempting to speculate that the persistent TRF1 bridges flanked by RTEL1 foci observed in this study (Supplemental Figure S3), may be similar to previously described ultrafine bridges flanked by Fanconi anemia complex proteins ([@B9]). Whereas ultrafine bridges were only rarely observed at telomeres, TRF1 bridges were observed almost exclusively at telomeres.

Telomere associations may lead to a combination of downstream events. Telomere bridges leading to chromatin breaks continue to fuse and break in subsequent cell cycles, giving rise to genomic instability ([@B31]). Anaphase bridges have been reported to lead to chromosome breaks at variable positions ([@B31]), with a preference for breakage at fragile sites---unstable regions of the genome that are prone to gaps, breaks, and genome rearrangements ([@B16]; [@B9]). Of note, telomeres have been reported to resemble fragile sites ([@B42]). We speculate that if chromatin bridges predominantly break at or near telomeric DNA, telomere associations could contribute to the marked heterogeneity in telomere length at any given telomere ([@B26]; [@B28]; [Figure 5C](#F5){ref-type="fig"}).

Our studies show that telomere associations are mediated by TRF1 and provide insight into the resolution and repair of these associations. Future studies will likely further reveal how this mechanism is mediated, what other factors within and outside the shelterin complex play a role, and how telomere associations affect cellular processes under physiological and pathological conditions.

MATERIALS AND METHODS
=====================

Plasmid constructs
------------------

Fluorescent TRF1 and H2B constructs were fused to fluorescent proteins as specified in the foregoing text. CAG-IRES-YFP was also fused to the N-terminus of a nuclear membrane--localizing domain, importin α1 fragment, as previously described ([@B38]). RTEL1 was fused to YFP and an FKBP degradation domain (FKBP12-L106P) as previously described ([@B3]; [@B46]). These cells were grown in the presence of Shield-1 to stabilize RTEL1-YFP and transiently transfected with RFP-TRF1 for ∼72 h. An FKBP degradation domain was fused to the N-terminus of cleavable TRF1 (FKBP-YFP-TRF1~TEV~). Expression of all constructs was driven by a CAG promoter, except for RTEL1-YFP, driven by a PGK promoter, and CFP-TEV protease, driven by a CAG or a PGK promoter as specified.

Cell culture, transfection, and FACS analysis
---------------------------------------------

Mouse ES cell lines (*Mus musculus*, 129 strain) were grown under standard culture conditions on 0.1% gelatin-coated dishes in the presence of leukemia inhibitory factor, as described previously ([@B19]). Transfection was performed using Effectene transfection reagent (Qiagen, Valencia, CA). Cell populations expressing defined TRF1 levels were obtained by transfecting cells with YFP-TRF1, TRF1~IRES-YFP~, or FKBP-YFP-TRF1~TEV~ followed by FACS (BD/Cytopeia Influx; BD Biosciences, San Jose, CA). FACS data were analyzed using FlowJo software (Treestar, Ashland, OR). The generation of RTEL1-deficient cell lines was previously described ([@B15]).

Preparation of whole-cell extracts and Western blotting
-------------------------------------------------------

Whole-cell extracts were prepared of cells transiently expressing TRF1~IRES-YFP~ or YFP-TRF1 and sorted for low, high, or high++ YFP levels grown to ∼80% confluence. At 48 h posttransfection, cells were harvested by trypsinization, incubated in NuPAGE LDS-reducing sample buffer (Invitrogen, Carlsbad, CA), and stored at −20°C until use. Samples were heated to 70°C for 10 min before separation by SDS--PAGE (Invitrogen). After transfer to a nitrocellulose membrane (Bio-Rad, Hercules, CA), membrane strips were blocked (5% nonfat dry milk and 0.1% Tween 20 in phosphate-buffered saline \[PBS-MT\]) for 1 h and incubated overnight with rabbit anti-mouse TRF1 (1:500 in PBS-MT; a kind gift from Y. Shinkai), anti--green fluorescent protein (1:50,000 in PBS-MT; Ab290; Abcam, Cambridge, UK), or glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Research Diagnostics, Cleveland, OH) loading control. Proteins were detected by chemiluminescence (SuperSignal West Pico; Pierce, Thermo Scientific, Rockford, IL).

Immunostaining and TRF1 foci count
----------------------------------

A cell clone stably expressing low levels of YFP-TRF1 was generated, and these cells were fixed in suspension with 4% formaldehyde in PBS for 20 min, permeabilized in 0.2% NP-40 in PBS, blocked with 1% bovine serum albumin, incubated with rabbit anti--phospho-histone H3 (Ser-10) (06-570; Upstate, Millipore, Billerica, MA) conjugated to goat anti-rabbit Cy5 (111-175-003; Jackson Immuno­Research, West Grove, PA), and stained with 4′,6-diamidino-2-phenylindole (DAPI). Cells were sorted into G1-, S-, and G2/M-based DAPI DNA content, and an anti--phospho-histone H3 (Ser-10; Supplemental Figure S1) using the BD/Cytopeia cell sorter. Image stacks of 20 whole cells were acquired from each sorted cell population (*z*-section spacing, 0.2 μm). Image analysis was performed using Volocity (Improvision, Perkin Elmer, Coventry, UK) to select TRF1 foci.

Live-cell imaging
-----------------

Cells were grown in No. 1.5 LabTek II chambered coverglasses (Nalge NUNC, Rochester, NY). To adhere gelatin to the glass, the glass was coated with 0.1% gelatin, air dried, fixed with 4% paraformaldehyde for 2 h, and rinsed thoroughly with PBS. Cells grown using this method had normal morphology compared with standard gelatin-coated plastic dishes. Live-cell imaging was performed using a DeltaVision RT system (Applied Precision, Seattle, WA) with an Olympus IX inverted microscope and a CoolSnap HQ charge-coupled device camera (Roper Scientific, Tucson, AZ). Excitation and emission filters used were as follows: CFP, 436/10 and 465/30 nm; YFP, 492/18 and 535/30 nm; and RFP, 580/20 and 630/60 nm. Images were acquired using a 60× PlanApo 1.4 numerical aperture oil objective (Olympus). An environmental chamber was used at 37°C with 5% CO~2~ perfusion. Image analysis was performed using SoftWoRx Suite (Applied Precision) and Volocity.

TRF1 bridges and mitotic bypass
-------------------------------

Cells were imaged starting in metaphase with image stacks (15 images; *z*-section spacing, 1 μm) acquired at 5-min intervals. Exposure was 0.2 s, and neutral density filters (transmission 10%) were used to minimize photobleaching. To obtain populations of cells with high and high++ TRF1 levels, cells stably expressing low YFP-TRF1 levels were transfected a second time with YFP-TRF1 and sorted by FACS, followed by imaging at ∼20--30 h posttransfection and ∼3--10 h postsorting.

Metaphase spread preparation and telomere FISH
----------------------------------------------

Sorted cells overexpressing IRES-YFP, TRF1~IRES-YFP~, or YFP-TRF1 were treated with Colcemid (0.1 μg/ml) for 4 h before trypsin harvest. After washing and hypotonic swelling (75 mM KCl) for 3--5 min at 37°C, cells were fixed twice in methanol--acetic acid (3:1) at room temperature for 15 min, spread onto a precleaned slide, and air-dried overnight. Telomere FISH was previously described ([@B26]) using a Cy5-conjugated (C~3~TA~2~)~3~ peptide nucleic acid probe (Boston Probes, Applied Biosystems, Grand Island, NY). Images were acquired on an Axioplan 2 microscope (Carl Zeiss, Jena, Germany) with Isis 5 software (Metasystems) using an AxioCam MRm camera (Carl Zeiss).

TRF1 cleavage assay
-------------------

The same automatic thresholding of fluorescence intensity was used for all time points. Time points were selected at which the entire cell was in focus and ranged from 1 to 10 h before and after detection of CFP-TEV protease. TEV protease was fused to nuclear localization signals at the N- and C-termini (CFP-NLS-TEV protease-NLS-NLS), to facilitate nuclear entry of TEV protease ([@B39]). The TEV protease recognition site ENLYFQGx3 was inserted in the flexible hinge region of *mTrf1* using similar methods to [@B39]. An *Hpa*I site was introduced into TRF1 (amino acid position 338) by site-directed mutagenesis using the oligonucleotide 5′-GAAACAACGATGGAA[GTTAAC]{.ul}CGAAGAACC-3′. The TEV protease recognition site ENLYFQGx3 was then inserted at the *Hpa*I site using the oligonucleotide 5′-PHOSPHATE-[AAC]{.ul}GCTCTAGA­GAA­TTTGTATTTTCAGGG­TGCTTC­TGAAAACCTTTACTTCCAAGGAGAGCTCGAAAATCTTTATTTCCAGGGA[GTT]{.ul}-3′.
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